Bellicum Pharmaceuticals

Axovant Sciences

Axovant Sciences is a leading clinical-stage biopharmaceutical company focused on acquiring, developing and commercializing novel therapeutics for the treatment of dementia. Axovant intends to develop a pipeline of product candidates to comprehensively address the cognitive, functional and behavioral aspects of dementia and related neurological disorders. Its vision is to become the leading company focused on the treatment of dementia by addressing all forms and aspects of this condition.
www.axovant.com